Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib

Treatment with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has been shown to prolong survival in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). The present study performed a retrospective analysis to investigate the association between the plasma...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Clin Oncol
Autori principali: INOMATA, MINEHIKO, HAYASHI, RYUJI, TANAKA, HIROAKI, SHIMOKAWA, KAZUKI, TOKUI, KOTARO, TAKA, CHIHIRO, OKAZAWA, SEISUKE, KAMBARA, KENTA, ICHIKAWA, TOMOMI, YAMADA, TORU, MIWA, TOSHIRO, KASHII, TATSUHIKO, MATSUI, SHOKO, TOBE, KAZUYUKI
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2016
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840529/
https://ncbi.nlm.nih.gov/pubmed/27123277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.779
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi